We are live on ! Find out more
BCYC

Bicycle Therapeutics
BCYC

16 hedge funds and large institutions have $98.9M invested in Bicycle Therapeutics in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

16% more capital invested

Capital invested by funds: $85.1M → $98.9M (+$13.7M)

14% more funds holding

Funds holding: 14 → 16 (+2)

0.33% more ownership

Funds ownership: 34.43% → 34.76% (+0.33%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
4
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.25M
2
Renaissance Technologies
Renaissance Technologies
New York
+$859K
3
Osaic Holdings
Osaic Holdings
Arizona
+$523K
4
California Public Employees Retirement System
California Public Employees Retirement System
California
+$288K
5
Millennium Management
Millennium Management
New York
+$47.2K

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$3.56M
2
Squarepoint
Squarepoint
New York
-$42.1K
3
CSS
Cubist Systematic Strategies
Connecticut
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tybourne Capital Management
Hong Kong
$30.8M – – –
SHI
2
SV Health Investors
Massachusetts
$30.1M – – –
AVA
3
Atlas Venture Advisors
Massachusetts
$21.4M – – –
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$6.3M – – –
Fidelity Investments
5
Fidelity Investments
Massachusetts
$3.28M +$3.25M +211,444 New
Victory Capital Management
6
Victory Capital Management
Texas
$3.23M -$3.56M -231,885 -53%
Renaissance Technologies
7
Renaissance Technologies
New York
$1.18M +$859K +55,900 +297%
LCM
8
Laurion Capital Management
New York
$897K – – –
Osaic Holdings
9
Osaic Holdings
Arizona
$537K +$523K +34,000 +34,000%
California Public Employees Retirement System
10
California Public Employees Retirement System
California
$291K +$288K +18,745 New
Millennium Management
11
Millennium Management
New York
$284K +$47.2K +3,073 +20%
PCM
12
Pentwater Capital Management
Florida
$197K – – –
Squarepoint
13
Squarepoint
New York
$163K -$42.1K -2,738 -21%
Morgan Stanley
14
Morgan Stanley
New York
$55K +$3.37K +219 +7%
UBS Group
15
UBS Group
Switzerland
$36K +$35.1K +2,285 New
CSS
16
Cubist Systematic Strategies
Connecticut
– -$4K -294 Closed
VFA
17
Valeo Financial Advisors
Indiana
– +$92 +6 New

BCYC Hedge Fund Activity: Q2 2020 in Review

16 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q2 2020, worth a combined $98.9M — up 16% from $85.1M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BCYC positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $3.25M. The largest seller was Victory Capital Management, cutting an estimated $3.56M.

  • 16 institutional investors held Bicycle Therapeutics (BCYC) as of Q2 2020, up from 14 in Q1 2020.
  • Funds reported $98.9M of Bicycle Therapeutics stock for Q2 2020, up 16% quarter-over-quarter.
  • 4 funds opened new Bicycle Therapeutics positions in Q2 2020 and 2 closed out, a net change of +2 holders.
  • The largest Bicycle Therapeutics buyer in Q2 2020 was Fidelity Investments, an estimated $3.25M added.
  • The largest Bicycle Therapeutics seller in Q2 2020 was Victory Capital Management, an estimated $3.56M sold.

Based on aggregated 13F filings for Q2 2020.